{
    "root": "2258caa0-a7b0-f973-e063-6394a90ac5e0",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Tinidazole",
    "value": "20250320",
    "ingredients": [
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_181906"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        },
        {
            "name": "ALUMINUM OXIDE",
            "code": "LMI26O6933",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25741"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TINIDAZOLE",
            "code": "033KF7V46H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_63627"
        }
    ],
    "indications": {
        "text": "1.1 trichomoniasis tinidazole indicated treatment trichomoniasis caused trichomonas vaginalis . organism identified appropriate diagnostic procedures . trichomoniasis sexually transmitted disease potentially serious sequelae , partners infected patients treated simultaneously order prevent re-infection [ ( 14.1 ) ] . 1.2 giardiasis tinidazole indicated treatment giardiasis caused giardia duodenalis ( also termed g. lamblia ) adults pediatric patients older three years age [ ( 14.2 ) ] . 1.3 amebiasis tinidazole indicated treatment intestinal amebiasis amebic liver abscess caused entamoeba histolytica adults pediatric patients older three years age . indicated treatment asymptomatic cyst passage [ ( 14.3 , 14.4 ) ] . 1.4 bacterial vaginosis tinidazole indicated treatment bacterial vaginosis ( formerly referred haemophilus vaginitis , gardnerella vaginitis , nonspecific vaginitis , anaerobic vaginosis ) adult women [ ( 8.1 ) ( 14.5 ) ] . pathogens commonly associated vulvovaginitis trichomonas vaginalis , chlamydia trachomatis , neisseria gonorrhoeae , candida albicans herpes simplex virus ruled . 1.5 usage reduce development drug-resistant bacteria maintain effectiveness tinidazole antibacterial drugs , tinidazole used treat prevent infections proven strongly suspected caused susceptible bacteria . culture susceptibility information available , considered selecting modifying antibacterial therapy . absence data , local epidemiology susceptibility patterns may contribute empiric selection therapy .",
        "doid_entities": [
            {
                "text": "trichomoniasis (DOID:1947)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1947"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "giardiasis (DOID:10718)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10718"
            },
            {
                "text": "amebiasis (DOID:9181)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9181"
            },
            {
                "text": "bacterial vaginosis (DOID:3385)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3385"
            },
            {
                "text": "vaginitis (DOID:2170)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2170"
            },
            {
                "text": "vulvovaginitis (DOID:2273)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2273"
            },
            {
                "text": "chlamydia (DOID:11263)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11263"
            },
            {
                "text": "herpes simplex (DOID:8566)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8566"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "2",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "tinidazole 500 mg tablets pink , oval , scored tablets , tm debossed one side 500 , supplied bottles child-resistant caps : ndc 44523-450-20 bottle 20 ndc 44523-450-12 bottle 12 storage : store controlled room temperature 20-25\u00ba c ( 68-77\u00ba f ) ; excursions permitted 15-30\u00ba c ( 59-86\u00ba f ) [ usp ] . protect contents light .",
    "adverseReactions": "tinidazole contraindicated : patients previous history hypersensitivity tinidazole nitroimidazole derivatives . reported ranged severity urticaria stevens-johnson syndrome [ ( 6.1 , 6.2 ) ] . patients cockayne syndrome . severe irreversible hepatotoxicity/acute liver failure fatal outcomes reported initiation metronidazole , another nitroimidazole , structurally related tinidazole , patients cockayne syndrome [ ( 6.2 ) ]",
    "indications_original": "1.1 Trichomoniasis\n                  \n                  Tinidazole is indicated for the treatment of trichomoniasis caused by \n  Trichomonas vaginalis. The organism should be identified by appropriate diagnostic procedures. Because trichomoniasis is a sexually transmitted disease with potentially serious sequelae, partners of infected patients should be treated simultaneously in order to prevent re-infection \n  [see Clinical Studies (14.1)].\n                  \n                  \n                  \n                     1.2 Giardiasis\n                  \n                  Tinidazole is indicated for the treatment of giardiasis caused by \n  Giardia duodenalis (also termed G. lamblia) in both adults and pediatric patients older than three years of age \n  [see Clinical Studies (14.2)].\n                  \n                  \n                  \n                     1.3 Amebiasis\n                  \n                  Tinidazole is indicated for the treatment of intestinal amebiasis and amebic liver abscess caused by \n  Entamoeba histolytica in both adults and pediatric patients older than three years of age. It is not indicated in the treatment of asymptomatic cyst passage \n  [see Clinical Studies (14.3, 14.4)].\n                  \n                  \n                  \n                     1.4 Bacterial Vaginosis\n                  \n                  Tinidazole is indicated for the treatment of bacterial vaginosis (formerly referred to as \n  Haemophilus vaginitis, \n  Gardnerella vaginitis, nonspecific vaginitis, or anaerobic vaginosis) in adult women \n  [see Use in Specific Populations (8.1) and Clinical Studies (14.5)].\n                  \n                  Other pathogens commonly associated with vulvovaginitis such as \n  Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, Candida albicans and \n  Herpes simplex virus should be ruled out.\n \n                  \n                  \n                     1.5 Usage\n                  \n                  To reduce the development of drug-resistant bacteria and maintain the effectiveness of tinidazole and other antibacterial drugs, tinidazole should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
    "contraindications_original": "2 DOSAGE AND ADMINISTRATION",
    "warningsAndPrecautions_original": "Tinidazole 500 mg tablets are pink, oval, scored tablets, with TM debossed on one side and 500 on the other, supplied in bottles with child-resistant caps as:\n  \n                     NDC 44523-450-20 Bottle of 20\n  \n                     NDC 44523-450-12 Bottle of 12\n  \nStorage: Store at controlled room temperature 20-25\u00ba C (68-77\u00ba F); excursions permitted to 15-30\u00ba C (59-86\u00ba F) [see USP]. Protect contents from light.",
    "adverseReactions_original": "The use of tinidazole is contraindicated:\n                  \n                     In patients with a previous history of hypersensitivity to tinidazole or other nitroimidazole derivatives. Reported reactions have ranged in severity from urticaria to Stevens-Johnson syndrome\n    [see Adverse Reactions (6.1, 6.2)].\n                     \n                     In patients with Cockayne syndrome. Severe irreversible hepatotoxicity/acute liver failure with fatal outcomes have been reported after initiation of metronidazole, another nitroimidazole drug, structurally related to tinidazole, in patients with Cockayne syndrome \n   [see Adverse Reactions (6.2)]",
    "drug": [
        {
            "name": "Tinidazole",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_63627"
        }
    ]
}